Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krishna Institute of Medical Sciences (NSE:KIMS) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Krishna Institute of Medical Sciences Forward PE Ratio Related Terms
Krishna Institute of Medical Sciences Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences Forward PE Ratio Chart
Krishna Institute of Medical Sciences Annual Data
Trend
2023-03
2025-03
2026-03
Forward PE Ratio
29.15
56.02
50.70
Krishna Institute of Medical Sciences Quarterly Data
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
2026-06
Forward PE Ratio
26.81
34.84
32.15
29.15
36.76
40.65
34.72
52.05
56.02
58.78
71.64
44.41
50.70
74.11
NSE:KIMS vs HCA, THC, DVA: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's Forward PE Ratio falls into.
Krishna Institute of Medical Sciences Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Krishna Institute of Medical Sciences (NSE:KIMS) has a Forward PE Ratio of 79.84 as of Aug. 14, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Krishna Institute of Medical Sciences and its competitors. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #288 out of 315 companies in the Healthcare Providers & Services industry, placing it in the top 91.4%.
Is Krishna Institute of Medical Sciences' Forward PE Ratio too high?
Krishna Institute of Medical Sciences' current Forward PE Ratio is 79.84. The Healthcare Providers & Services industry median Forward PE Ratio is 19.02. Krishna Institute of Medical Sciences' value of 79.84 is 319.8% above this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #288 out of 315 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #288 out of 315 companies for Forward PE Ratio. This places Krishna Institute of Medical Sciences in the lower half of its industry. The industry median Forward PE Ratio is 19.02. Krishna Institute of Medical Sciences' value of 79.84 is 319.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 19.02, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current Forward PE Ratio of 79.84 is 319.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 19.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current Forward PE Ratio is 79.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹859.12, compared to a current price of ₹807.55 — trading 6% below its estimated fair value. The current Forward PE Ratio is 79.84 and 319.8% above the Healthcare Providers & Services industry median of 19.02. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Forward PE Ratio is 79.84 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued.
The current stock price of ₹807.55 is trading 6% below its estimated GF Value™ of ₹859.12.
GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.
Key valuation signals for NSE:KIMS:
Forward PE Ratio: 79.84
GF Value™: ₹859.12 vs. price of ₹807.55 (6% below fair value)
Industry Position: 319.8% above the Healthcare Providers & Services median (#288 of 315)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score
Get the complete analysis for NSE:KIMS
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
